29
October
2020
|
22:59
Europe/Amsterdam

The latest in the fight against COVID-19

Keep up to date with developments on COVID-19 with NUS News

 

 

Lab 2.jpg

11 November 2020  (General News)

Since the start of the COVID-19 outbreak, NUS experts have routinely contributed commentaries to the media to help the public make sense of the situation. Advances in research at NUS have also been covered by the newspapers. 

To see the media's coverage of NUS' contributions to the fight against COVID-19, click here.   

 

04 November 2020  (Research - Impact)

NUS researchers have developed an automated system that collates and displays users’ blood oxygen data on an easy-to-read dashboard. It is suitable for places such as dormitories and community care facilities to provide frontline staff with regular updates on the health status of residents under their care. To read more, click here

 

Photograph 1 (credit NUS).JPG

20 October 2020  (Research - Impact)

NUS spin-off Breathonix Pte Ltd has developed an easy-to-use breath test that detects COVID-19 within a minute. This technology has achieved more than 90 per cent accuracy in a pilot clinical trial involving 180 patients, and could potentially be deployed in airports and dormitories. To read more, click here

 

covid_0.jpg

30 September 2020  (Research - Insights)

NUS experts have identified five key factors for strategies to ease lockdown restrictions after comparing responses in Europe and Asia Pacific.

To read more, click here.   

 

Screen Shot 2020-09-07 at 1.33.24 PM.jpg

7 September 2020  (Research - Impact)

An NUS Libraries Digital Scholarship team has collaborated with the National Centre for Infectious Diseases to build a platform showcasing the research done in Singapore on infectious diseases as well as the people involved in the field.

To read more, click here.    

 

P5150151.JPG

24 August 2020  (Research - Impact)

New SARS-CoV-2 variant causes less severe infections. Duke-NUS researchers, together with collaborators from the National Centre for Infectious Diseases and A*STAR’s Singapore Immunology Network, have shown that COVID-19 patients infected with a new variant of SARS-CoV-2 had better clinical outcomes. To read more, click here.    

 

14-scaled.jpg

14 August 2020  (Research - Insights)

Many different vaccines and drugs are being developed and tested at a record-busting pace, thanks to an unprecedented level of worldwide collaboration. Dr Khor Ing Wei from the Dean's Office at the NUS Yong Loo Lin School of Medicine outlines the latest developments. To read more, click here.   

 

lunar-cov19.jpg

   22 July 2020  (Research - Impact)

A vaccine jointly developed by Duke-NUS Medical School and US pharmaceutical company Arcturus Therapeutics has received approval for clinical trials. Pre-clinical studies of the vaccine have shown very promising findings. A single dose might be sufficient to trigger a robust and durable immune response against the coronavirus.

To read more, click here

   

coronavirus.jpg

   16 July 2020  (Research - Impact)

NUS Engineers join the battle against COVID-19, driving forward innovations to meet the challenges posed by the pandemic on a broad range of fronts covering treatment, testing and infection prevention.

To read more, click here

   

singapore-scientists-uncover-sars-cov-2-specific-t-cell-immunity.jpg

   16 July 2020  (Research - Impact)

Duke-NUS scientists uncover SARS-CoV-2-specific T cell immunity in recovered COVID-19 & SARS patients, and in uninfected individuals. Infection and exposure to coronaviruses induces long-lasting memory T cells, which could help in the management of the current pandemic.

To read more, click here

     

Photograph A_960x540.jpg

   13 July 2020  (Research - Impact)

Two multidisciplinary research teams from NUS have developed three nasopharyngeal swabs designs to help address the global shortage, and to ensure Singapore has a sustainable supply. More than 40 million of these new NUS-designed, clinically-tested swabs are being produced in Singapore.

To read more, click here

 

Device-web.jpg

   29 June 2020  (Research - Impact)

A team of researchers from NUS Institute for Health Innovation & Technology has developed a portable COVID-19 micro-PCR diagnostic system, Epidax, that enables accurate on-site screening to be completed in about one hour.

To read more, click here

  

GettyImages-1215989355.jpg

   26 June 2020  (Research - Insights)

Dr Ong Qiyan from NUS Social Service Research Centre shares the centre’s COVID-19 Social Data Bank initiative to aid social services in identifying gaps and emerging trends during the pandemic.

To read more, click here

  

Photo B_960x540.jpg

   25 June 2020  (Research - Impact)

An NUS-NUH research team has developed a reusable protective barrier which lowers the risk of frontline healthcare workers being exposed to COVID-19 via droplets and aerosols when they look after patients.

To read more, click here

  

newsinfomain_COVID19Antibodies_200617 copy.jpg

   17 June 2020  (Research - Impact)

Scientists from NUS and DSO National Laboratories have developed five human monoclonal antibodies with potent neutralising activity for SARS-CoV-2 virus which could represent powerful new therapeutic or prophylactic candidate medicines to combat COVID-19.

To read more, click here

  

NUS COVID research 2.jpg

   9 June 2020  (Research - Impact)

In the second of a two-part series outlining how research from NUS is combatting COVID-19, this article shows how researchers use information and technology to explore everything from modelling public health to fighting false rumours online.

To read more, click here

  

covid19 research.png

   2 June 2020  (Research - Impact)

In the first of a two-part series highlighting how NUS is taking on COVID-19, this article outlines the seed funding available for new innovative research, and current research ranging from diagnostic tests to vaccine development.

To read more, click here

 

HDB blocks.jpg

   1 June 2020  (Research - Insights)

COVID-19 has led to a substantial loss in income for many households, while posing a liquidity problem for financial markets. NUS Business professors analyse the situation.

To read more, click here

 

saw swee hock 906.jpg

   18 May 2020  (Research - Insights)

Since Singapore saw its first case of COVID-19 on 24 January 2020, the Saw Swee Hock School of Public Health (SSHSPH) has collated the emerging evidence base and produced the SSHSPH COVID-19 Science Report for researchers, policymakers and regional colleagues.

To read more, click here

 

serology test 960.jpg

   15 May 2020  (Research - Impact)

Duke-NUS Medical School researchers have developed a serology test that takes just an hour to detect if someone has been infected with COVID-19 before. The test will be a huge boost for COVID-19 investigations and vaccine development.

To read more, click here

 

Empty airport.jpg

   11 May 2020  (Research - Insights)

With the COVID-19 outbreak dragging the world into a massive recession, NUS Business and NUS East Asian Institute professors look at Asian governments’ monetary and fiscal packages to stem the economic damage from the pandemic. In the longer run, the world has to digest the current huge increase in government debt and deficits.

To read more, click here

 

conversation-on-the-2020-pandemic.jpg

   28 Apr 2020  (Research - Insights)

With the COVID-19 outbreak dragging the world into a massive recession, NUS Business professors provide an overview of the prospects for an economic recovery.

To read more, click here

 

lockdown.jpg

   15 Apr 2020  (Research - Insights)

Professor Teo Yik Ying, Dean of the NUS Saw Swee Hock School of Public Health, and Professor David L. Heymann from the London School of Hygiene and Tropical Medicine, discuss how global leaders must coordinate an exit from lockdowns to prevent chains of transmission from recurring.

To read more, click here

 

2profs_960.jpg

 26 Mar 2020  (Research - Innovators)

Professor Wang Linfa and Assistant Professor Danielle Anderson from Duke-NUS Medical School speak about the breakthroughs and challenges they have faced in tackling COVID-19.

To read more, click here.

 

layout-1.jpg

 12 Mar 2020  (Research - Innovators)

Experts at NUS are leading the charge against COVID-19. From many different disciplines, the thought-leaders of NUS are taking on this challenge from multiple fronts. This article gives an overview of the collaborative members of this fight against a global crisis.

To read more, click here.

 

COVID-19.jpg

09 Mar 2020  (Research - Insights)

Professor Dale Fisher from the NUS Yong Loo Lin School of Medicine gives his expert insights into the current situation of COVID-19 in Singapore and the outlook for the disease in the future.

To read more, click here

 

vaccine.jpg

05 Mar 2020  (Research - Impact)

Duke-NUS and Arcturus Therapeutics, a leading messenger RNA medicines company, have announced their partnership to develop a COVID-19 vaccine for Singapore. The vaccine will take advantage of the unique platform developed at Duke-NUS which allows rapid screening of vaccines for effectiveness and safety

To read more, click here.

 

infectious disease.jpg

04 Mar 2020  (Research - Insights)

NUS researchers, in collaboration with scientists and doctors from several Singaporean medical institutes, have written a report detailing the initial experience in Singapore for the first 18 patients affected by COVID-19.

To read more, click here

 

virus_comics_3.jpg

04 Mar 2020  (EducationCommunity

An educational comic from NUS about the COVID-19 outbreak has been highlighted by the World Health Organization (WHO), which asked for it to be shared widely to help sensitise people to the prevention of COVID-19.

To read more, click here.

 

Prof Lee and Prof Yue.jpg

   28 Feb 2020  (General News)

Amid the COVID-19 outbreak, there have been many false rumours circulating on social media about the virus, inciting fear and paranoia among people.

Click here to read about the new Centre for Trusted Internet and Community, which will engage in the multi-disciplinary study of the Internet and address such issues. Click here for a Q&A with the centre’s leaders as they discuss the implications of the rise of social media.

 

IPS Forum.JPG

   28 Feb 2020  (Research - Insights)

How has Singapore rallied to the fight against COVID-19? A forum by the Institute of Policy Studies examined the impact of the coronavirus on the nation and how it responded, summing up the good, the bad and the ugly.

To read more, click here

 

COVID vaccine.jpg

       27 Feb 2020  (Research - Impact)

Researchers from the NUS Saw Swee Hock School of Public Health have reviewed potential diagnostics, vaccines and therapeutics for COVID-19 to guide policymakers on allocating resources for research and development.

To read more, click here.

 

virus_comics_1a.jpg

   21 Feb 2020  (EducationCommunity

Members of the NUS community have published creative and educational comics on the COVID-19 outbreak, to help reassure and share knowledge with the general public. 

To read more, click here. Read “Baffled Bunny” and “Curious Cat” series and The COVID-19 Chronicles.

 

Face masks.jpg

17 Feb 2020 (Research - Insights)

The COVID-19 situation may seem daunting now but Singapore will eventually overcome it, writes NUS Law Professor Tommy Koh. By sticking together, the country had previously overcome tough times.

To read more, click here.

 

envision_1.jpg

14 Feb 2020  (Research - Impact)

Scientists from the NUS community are working on a vaccine trial and rapid detection test kits, as they join the global effort to combat the COVID-19 virus.

To read more, click here.

 

duke-nus_virus.jpg

    04 Feb 2020  (Research - Impact)

Researchers from the Duke-NUS Medical School helped to successfully culture the COVID-19 coronavirus from an infected patient’s clinical sample.

To read more, click here

 

Food delivery.jpg

 04 Feb 2020  (Community)

The University is taking proactive steps to ensure the welfare of students and staff under leave of absence or quarantine due to the COVID-19 situation. 

To read more, click here